Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Laboratorios Farmaceuticos Rovi SA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 09 Jul 2020 | Moderna Enters Manufacturing Agreement with Rovi for COVID-19 Vaccine Candidate | Contract Service Agreement |
Moderna Inc
|
Laboratorios Farmaceuticos Rovi SA |
| 15 Feb 2019 | Laboratorios Farmaceuticos Rovi Acquires Certain Rights to Dexchlorpheniramine Maleate Product Line | Asset Transaction |
Laboratorios Farmaceuticos Rovi SA
|
Undisclosed
|
| 09 Jan 2019 | Laboratorios Farmaceuticos Rovi Acquires Falithrom from Hexal | Asset Transaction |
Laboratorios Farmaceuticos Rovi SA
|
Hexal AG
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer